XTL Biopharmaceuticals Ltd. (TLV:XTLB)
2.700
-0.100 (-3.57%)
At close: Dec 18, 2025
-51.79% (1Y)
| Market Cap | 23.80M |
| Revenue (ttm) | 1.64M |
| Net Income (ttm) | -3.74M |
| Shares Out | 881.39M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,067,516 |
| Average Volume | 1,678,766 |
| Open | 2.800 |
| Previous Close | 2.800 |
| Day's Range | 2.600 - 2.800 |
| 52-Week Range | 2.600 - 11.800 |
| Beta | 0.92 |
| RSI | 30.44 |
| Earnings Date | Mar 12, 2026 |